H.R. 3253 - 116th Congress (2019-2020) - Sustaining Excellence in Medicaid Act of 2019

makes appropriations through FY2024 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program;
allows state Medicaid fraud control units to review complaints regarding patients who are in noninstitutional or other settings;
temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services;
temporarily extends the Medicaid demonstration program for certified community behavioral health clinics;
repeals the requirement, under the Medicaid Drug Rebate Program, that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations; and
increases funding available to the Medicaid Improvement Fund beginning in FY2021.

Text (5)

Enrolled Bill

Engrossed Amendment Senate

July 25, 2019

Received in Senate

June 19, 2019

Engrossed in House

June 18, 2019

Introduced in House

June 13, 2019

Amendments (1)

Jul 25, 2019

Agreed to in Senate

Sponsorship

Senate Amendment 930

In the nature of a substitute.

Agreed To

Actions (22)

Show Only Major Actions

08/06/2019

Became Public Law No: 116-39.

08/06/2019

Signed by President.

08/01/2019

Presented to President.

07/30/2019

Motion to reconsider laid on the table Agreed to without objection.

07/30/2019

On motion that the House agree to the Senate amendment Agreed to without objection. (text: CR H7477-7478)

07/30/2019

Resolving differences -- House actions: On motion that the House agree to the Senate amendment Agreed to without objection.(text: CR H7477-7478)

07/30/2019

Ms. Norton asked unanimous consent to take from the Speaker's Table and agree to the Senate amendment. (consideration: CR H7477-7478)

07/25/2019

Message on Senate action sent to the House.

07/25/2019

Passed Senate with an amendment by Voice Vote.

07/25/2019

Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.

07/25/2019

Measure laid before Senate by unanimous consent. (consideration: CR S5114)

06/19/2019

Received in the Senate, read twice.

06/18/2019

Motion to reconsider laid on the table Agreed to without objection.

06/18/2019

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 371 - 46 (Roll no. 333). (text: CR H4706-4707)

06/18/2019

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 371 - 46 (Roll no. 333).(text: CR H4706-4707)

06/18/2019

Considered as unfinished business. (consideration: CR H4751)

06/18/2019

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

06/18/2019

DEBATE - The House proceeded with forty minutes of debate on H.R. 3253.

06/18/2019

Considered under suspension of the rules. (consideration: CR H4706-4710)

06/18/2019

Mrs. Dingell moved to suspend the rules and pass the bill, as amended.

06/13/2019

Referred to the House Committee on Energy and Commerce.

06/13/2019

Introduced in House

Public Record

Record Updated

Nov 1, 2022 1:51:05 PM